The device remains implanted in the patient and is therefore, not available for analysis.Medical records and imaging were provided and reviewed by an internal clinical representative with the following impression: adequate medical documentation and suboptimal imaging studies were available for this review.Product use was incongruent with the ifu due to the 29% change in the aortic neck diameter and greater than 90 degree angulation of the left common iliac artery.Cautionary product use conditions that might have contributed to this event included: bilateral iliac artery tortuosity and the moderate-severe calcifications.Intraoperatively, there was evidence to support a type ia endoleak intra-operative for which an additional vela stent was placed.One month post implant, there was evidence to support an unknown endoleak; a differential diagnosis between a type ia or ii endoleak could not be established.There was no evidence of rendered treatment.The final patient disposition could not be established, but the aneurysm sac was noted to be decreasing in size on the last known ct scan.Reportedly, the patient is stable.A manufacturing record review was performed, the lot met all release criteria with no issues or deviations that would explain the reported event.The lot usage history showed no other units from this lot were involved in any similar event.The product labeling was reviewed and confirmed that the reported event is adequately captured in the existing labeling.Based upon the investigation findings, the root cause could not be determined based upon available information.
|